This review highlights that additional ADP receptors beyond P2Y1 are involved in platelet aggregation, laying the mechanistic groundwork for understanding purinergic signaling in thrombosis.
Answers are grounded in this paper and cite their sources.
Suggests redundant ADP signaling in platelets; leaves open validation of additional receptors as antithrombotic targets.
The recent generation of mice deficient for the P2Y 1 receptor has allowed us to directly examine the contribution of this nucleotide receptor in ADP‐induced aggregation both in isolated platelets and in vivo thrombosis. Studies utilizing the P2Y 1 ‐deficient platelets clearly demonstrated that the P2Y 1 receptor alone is not sufficient for describing the various effects induced by ADP on platelets. While no increase in intracellular calcium was observed in the platelets lacking P2Y 1 , the ability of ADP to decrease intracellular cAMP was unaltered. An additive and unexpected observation is the partial aggregation induced by exposure of P2Y 1 ‐deficient platelets to high levels of ADP. This suggests that additional ADP receptors are expressed by platelets and that these receptors can induce partial aggregation of platelets in the absence of measurable changes in intracellular calcium. This review summarizes the recent advances in understanding the mechanisms involved in the platelet response to ADP and examines various hypotheses that attempt to explain the pathway leading to partial aggregation of P2Y 1 platelets in response to ADP. Drug Dev. Res. 52:150–155, 2001.
No takes yet. Share an insight, caveat, or question.
Fabre et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: